• Title of article

    N-(2-(4-hydroxyphenyl)ethyl)-4-chlorocinnamide: A novel antagonist at the 1 /2B NMDA receptor subtype

  • Author/Authors

    Amir P. Tamiz، نويسنده , , Edward R. Whittemore، نويسنده , , Robert M. Schelkun، نويسنده , , Po-Wai Yuen، نويسنده , , Richard M. Woodward، نويسنده , , Sui-Xiong Cai، نويسنده , , Eckard Weber، نويسنده , , John F. W. Keana، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 1998
  • Pages
    2
  • From page
    199
  • To page
    200
  • Abstract
    A series of N-(2-phenethyl)cinnamides was synthesized and assayed for antagonism at three N-methyl-d-asparate (NMDA) receptor subtypes (NR1 /2A-C). N-(2-(4-hydroxyphenyl)ethyl)-4-chlorocinnamide (6) was identified as a highly potent and selective antagonist of the NR1 /2B subtype. A series of N-(2-phenethyl)cinnamides was synthesized and assayed for antagonism at three N-methyl-d-asparate (NMDA) receptor subtypes (NR1 /2A-C). N-(2-(4-hydroxyphenyl)ethyl)-4-chlorocinnamide ( ) was identified as a highly potent and selective 1 /2B antagonist of NR1 /2B.
  • Journal title
    Bioorganic & Medicinal Chemistry Letters
  • Serial Year
    1998
  • Journal title
    Bioorganic & Medicinal Chemistry Letters
  • Record number

    789207